title: [Virostatic therapy of chronic hepatitis].
abstract: Interferons are glycoproteins which exert a potent inhibitory effect on the replication of hepatitis B virus (HBV). Controlled studies of interferon treatment in patients with chronic HBV infection have shown seroconversion rates, from HBeAg positive to anti-HBe positive, 2 to 3 times higher than without treatment. No enhancement of this effect was observed using combinations of interferon with other antiviral substances. The reason for poor therapeutic response to interferon in the majority of patients with chronic hepatitis B may result from its lost virostatic activity against HBV-DNA located in the cell nucleus.
authors: Zentrums Innere Medizin und Dermatologie, Medizinischen Hochschule Hannover.
authors: R
authors: R
authors: Müller
authors: H
authors: H
authors: Klein
authors: G
authors: G
authors: Niehoff
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006509:Hepatitis B / Q000628:therapy*; D006515:Hepatitis B virus / Q000187:drug effects; D006801:Humans; D007372:Interferons / Q000008:administration & dosage*; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D007372:Interferons
vernacular_title: Virostatische Therapie der chronischen Hepatitis.